Evidence map›Paper›PMID 36452480›Full record

ArticleComputational and mathematical methods in medicine2022

Pueraria lobata Potentially Treating Prostate Cancer on Single-Cell Level by Network Pharmacology and AutoDock: Clinical Findings and Drug Targets.

Yongfeng Mo, Manying Chen, Honyu Qin, Huaying Liu, Yu Ye

Open access · hybridAbstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yongfeng MoDepartment of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 53000, China.ORCID https://orcid.org/0000-0002-0047-165X
Manying ChenDepartment of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 53000, China.ORCID https://orcid.org/0000-0003-0425-6399
Honyu QinDepartment of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 53000, China.ORCID https://orcid.org/0000-0002-6738-5908
Huaying LiuDepartment of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 53000, China.ORCID https://orcid.org/0000-0003-1023-265X
Yu YeDepartment of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 53000, China.ORCID https://orcid.org/0000-0002-7025-436X
Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Prostate cancer (PCa) is one of the common malignant tumors of the urological system, and metastasis often occurs in advanced stages. Chemotherapy is an effective treatment for advanced PCa but has limitations in terms of efficacy, side effects, multidrug resistance, and high treatment costs. Therefore, new treatment modalities for PCa need to be explored and improved. Methods: R language and GEO database were used to obtain differentially expressed genes for PCa single-cell sequencing. TCMSP, STITCH, SwissTargetPrediction, and PubChem databases were used to obtain the active ingredients and targets of Results: Four active components and 31 target genes were obtained through the regulatory network of PL. Functional enrichment analysis showed that PL played a pharmacological role in the treatment of PCa by regulating the metabolic processes of reactive oxygen species, response to steroid hormones, and oxidative stress as well as IL-17 signaling pathway, PCa, and estrogen signaling pathway. Single-cell data showed that Conclusion: In this paper, a drug-active ingredient-target pathway network of PL at the single-cell level of PCa was constructed, and the findings revealed that it acted on genes such as

Indexed as

Prostatic NeoplasmsPuerariaApolipoproteins EHumansMaleMolecular Docking SimulationNetwork PharmacologyApolipoproteins E

Identifiers

PMID36452480
PMCPMC9705089
OpenAlexW4309756541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.